Ultrasound developer Misonix's Focus Surgery affiliate has received regulatory approvals in Europe and Japan for its Sonablate 500 (SB-500) system, which performs ultrasound prostate imaging and treatment.
SB-500 is capable of diagnostic-level imaging of the prostate and minimally invasive image-guided treatment of both benign and cancerous prostate tissue using high-intensity focused ultrasound (HIFU), according to Misonix of Farmingdale, NY. Misonix owns approximately 20% of Focus and has rights to produce its HIFU products.
By AuntMinnie.com staff writersAugust 10, 2001
Related Reading
Misonix hires Berger as scientific and industrial VP, May 18, 2001
Misonix to deliver SonoReal, April 6, 2001
Misonix completes purchase of Fibra Sonics, February 14, 2001
Misonix posts higher revenues, January 29, 2001
Misonix to acquire Fibra Sonics, December 15, 2000
Copyright © 2001 AuntMinnie.com
